1 – 20 of 31
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Usability and feasibility of PreventS-MD web app for stroke prevention
(
- Contribution to journal › Article
- 2023
-
Mark
Twenty years on from the introduction of the high risk strategy for stroke and cardiovascular disease prevention : a systematic scoping review
2023) In European Journal of Neurology(
- Contribution to journal › Scientific review
-
Mark
Factors Associated With Circulating Sex Hormones in Men
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Time to revise primary prevention guidelines for stroke and cardiovascular disease
(
- Contribution to journal › Letter
-
Mark
Atrial Fibrillation and Dementia : A Report From the AF-SCREEN International Collaboration
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Effects of Fluoxetine on Outcomes at 12 Months after Acute Stroke : Results from EFFECTS, a Randomized Controlled Trial
(
- Contribution to journal › Article
- 2020
-
Mark
The World Stroke Organization's Declaration for worldwide primary stroke and dementia prevention
(
- Contribution to journal › Article
-
Mark
Update on the EFFECTS study of fluoxetine for stroke recovery : A randomised controlled trial in Sweden
(
- Contribution to journal › Scientific review
-
Mark
What Is the Best Mix of Population-Wide and High-Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention?
(
- Contribution to journal › Scientific review
-
Mark
Characteristics of Recurrent Ischemic Stroke after Embolic Stroke of Undetermined Source : Secondary Analysis of a Randomized Clinical Trial
(
- Contribution to journal › Article
- 2019
-
Mark
Genetically Determined Risk of Depression and Functional Outcome After Ischemic Stroke
(
- Contribution to journal › Article
-
Mark
Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status : The NAVIGATE ESUS Trial
(
- Contribution to journal › Article
-
Mark
Genome-wide association meta-analysis of functional outcome after ischemic stroke
(
- Contribution to journal › Article
-
Mark
Searching for Atrial Fibrillation Poststroke : A White Paper of the AF-SCREEN International Collaboration
(
- Contribution to journal › Article
- 2018
-
Mark
Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial
(
- Contribution to journal › Article
- 2017
-
Mark
GISCOME – Genetics of Ischaemic Stroke Functional Outcome network : A protocol for an international multicentre genetic association study
(
- Contribution to journal › Article
-
Mark
Strategies to Improve Stroke Care Services in Low- and Middle-Income Countries : A Systematic Review
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source : Design of the NAVIGATE ESUS randomized trial
(
- Contribution to journal › Article
-
Mark
METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration : An initiative of the Joint Programme for Neurodegenerative Disease Research
(
- Contribution to journal › Article
- 2015
-
Mark
The Stroke Riskometer (TM) App: Validation of a data collection tool and stroke risk predictor
(
- Contribution to journal › Article